Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Genuine Parts Company (GPC) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Genuine Parts CompanyTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Genuine Parts Company vs Intuitive Surgical, Inc. — how do they compare? Genuine Parts Company trades at $126.99 (market cap $17.67B), while Intuitive Surgical, Inc. trades at $424.55 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 8.3× Genuine Parts Company's market cap, and Genuine Parts Company pays a 3.32% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and Intuitive Surgical, Inc. for 84 Days on average.

GPCISRG
Market Cap
$17.67B$146.76B
Volume
1,079,4582,529,814
Sector
Consumer CyclicalHealth
52-Week High
$149.26$592.85
52-Week Low
$92.47$332.02
Typical Hold Time
75 Days84 Days
Enterprise Value
$23.76B$141.54B
Dividend Yield
3.32%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Genuine Parts Company

GPC trades at $127.16, up 1.4% today, near its pivot point of $127 with technical indicators showing a bullish trend. The company reported mixed quarterly earnings, beating in Q1 and Q2 2026 but missing in Q4 2025, with Q3 2026 results due October 20. Revenue growth is steady, but net income margins have compressed significantly to 0.13% in 2025. Analysts maintain a consensus price target of $145.75, with 43% recommending Buy. Key developments include the planned spinoff of its industrial unit, Motion, scheduled for Q1 2027.

The outlook for GPC is cautiously optimistic, driven by the potential value unlock from the corporate split and its position in the resilient automotive aftermarket. However, thin profit margins and rising debt levels pose risks. The stock offers a dividend yield supported by its Dividend King status, but investors should weigh execution risks around the separation against the prospect of segment-specific reratings.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.

ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GPC

No sentiment data available yet.

ISRG
92% Buy8% Sell
Avg holding period · 84 Days

Top news

Latest headlines on both assets

About Genuine Parts Company

Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.

Read more on GPC →

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →